GJIC
CELG

Gamble Jones Investment Counsel’s Celgene Corp CELG Stock Holding History

Gamble Jones Investment Counsel’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,400
Closed -$227K – 240
2014
Q3 		$227K Buy
+2,400
New +$217K 0.03% 212

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gamble Jones Investment Counsel's CELG Position: Q4 2014 in Review

Gamble Jones Investment Counsel sold out of Celgene Corp (CELG) in Q4 2014, closing a stake of 2,400 shares — an estimated $227K sold.

Gamble Jones Investment Counsel first reported a position in CELG in Q3 2014 and held it in 1 quarter. The position peaked at $227K in Q3 2014. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Gamble Jones Investment Counsel reported no remaining Celgene Corp position as of Q4 2014 after selling out during the quarter.
  • Gamble Jones Investment Counsel sold 2,400 Celgene Corp shares in Q4 2014, an estimated $227K.
  • Gamble Jones Investment Counsel first reported a position in Celgene Corp in Q3 2014 and held it in 1 quarter.
  • Gamble Jones Investment Counsel's Celgene Corp position peaked at $227K in Q3 2014.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Gamble Jones Investment Counsel's 13F filing for Q4 2014, filed 9 Feb 2015.